In this context, it is important to characterize and explore the prevalence of CHEK2 variants among patients with cancer or hereditary cancer risk in Türkiye as these data will inform the counseling and care of patients or individuals with P/LPs vs. low-risk variants in CHEK2. Here, CHEK2 is linked to hereditary cancer.